These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test. Kitagawa Y; Imai K; Matsuoka M; Fukada A; Kubota K; Sato M; Takada T; Noguchi S; Tarumoto N; Maesaki S; Takeuchi S; Maeda T J Med Virol; 2022 Jan; 94(1):335-341. PubMed ID: 34524695 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients. Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients. Sun B; Feng Y; Mo X; Zheng P; Wang Q; Li P; Peng P; Liu X; Chen Z; Huang H; Zhang F; Luo W; Niu X; Hu P; Wang L; Peng H; Huang Z; Feng L; Li F; Zhang F; Li F; Zhong N; Chen L Emerg Microbes Infect; 2020 Dec; 9(1):940-948. PubMed ID: 32357808 [TBL] [Abstract][Full Text] [Related]
10. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies. Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z Front Immunol; 2020; 11():1936. PubMed ID: 32849650 [No Abstract] [Full Text] [Related]
11. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays. Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698 [TBL] [Abstract][Full Text] [Related]
12. The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19. Qin X; Shen J; Dai E; Li H; Tang G; Zhang L; Hou X; Lu M; Wu X; Duan S; Zhang J; Tsoi MF; Jiang P; Li Y BMC Immunol; 2021 Feb; 22(1):14. PubMed ID: 33596826 [TBL] [Abstract][Full Text] [Related]
13. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study. Al-Mughales JA; Al-Mughales TJ; Saadah OI Front Immunol; 2021; 12():705441. PubMed ID: 34539635 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay. Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654 [TBL] [Abstract][Full Text] [Related]
15. High clinical performance and quantitative assessment of antibody kinetics using a dual recognition assay for the detection of SARS-CoV-2 IgM and IgG antibodies. Mairesse A; Favresse J; Eucher C; Elsen M; Tré-Hardy M; Haventith C; Gruson D; Dogné JM; Douxfils J; Göbbels P Clin Biochem; 2020 Dec; 86():23-27. PubMed ID: 32858061 [TBL] [Abstract][Full Text] [Related]
16. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting. Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231 [TBL] [Abstract][Full Text] [Related]
17. Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course. Higgins V; Fabros A; Wang XY; Bhandari M; Daghfal DJ; Kulasingam V Clin Biochem; 2021 Apr; 90():1-7. PubMed ID: 33476578 [TBL] [Abstract][Full Text] [Related]
18. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies. Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733 [TBL] [Abstract][Full Text] [Related]
19. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies. Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280 [TBL] [Abstract][Full Text] [Related]
20. Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics. Padoan A; Cosma C; Sciacovelli L; Faggian D; Plebani M Clin Chem Lab Med; 2020 Jun; 58(7):1081-1088. PubMed ID: 32301749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]